5-Ht2b receptor antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 14, 2005
app pub date -
Aug 13, 2004
filing date -
Feb 13, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention concerns compounds of formula (I): wherein R.sup.1 is selected from the group consisting of H, and optionally substituted C.sub.1-6 alkyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl-C.sub.1-4 alkyl, and phenyl-C.sub.1-4 alkyl; R.sup.2 and R.sup.3 are either: (i) independently selected from H, R, R', SO.sub.2R, C(.dbd.O)R, (CH.sub.2).sub.nNR.sup.5R.sup.6, where n is from 1 to 4 and R.sup.5 and R.sup.6 are independently selected from H and R, where R is optionally substituted C.sub.1-4 alkyl group, and R' is an optionally substituted phenyl-C.sub.1-4 alkyl group, or (ii) together with the nitrogen atom to which they are attached, form an optionally substituted C.sub.5-7 heterocyclic group; R.sup.4 is an optionally substituted C.sub.9-14 aryl group; their use as pharmaceuticals, in particular for treating conditions alleviated by antagonism of a 5-HT.sub.2B receptor.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully